Abbasi_2017_Pak.J.Pharm.Sci_30_1715

Reference

Title : Synthesis, enzyme inhibition and molecular docking studies of 1-Arylsulfonyl-4-phenylpiperazine derivatives - Abbasi_2017_Pak.J.Pharm.Sci_30_1715
Author(s) : Abbasi MA , Anwar A , Rehman A , Siddiqui SZ , Rubab K , Shah SAA , Lodhi MA , Khan FA , Ashraf M , Alam U
Ref : Pak J Pharm Sci , 30 :1715 , 2017
Abstract :

Heterocyclic molecules have been frequently investigated to possess various biological activities during the last few decades. The present work elaborates the synthesis and enzymatic inhibition potentials of a series of sulfonamides. A series of 1-arylsulfonyl-4-Phenylpiperazine (3a-n) geared up by the reaction of 1-phenylpiperazine (1) and different (un)substituted alkyl/arylsulfonyl chlorides (2a-n), under defined pH control using water as a reaction medium. The synthesized molecules were characterized by 1H-NMR, 13C-NMR, IR and EI-MS spectral data. The enzyme inhibition study was carried on alpha-glucosidase, lipoxygenase (LOX), acetyl cholinesterase (AChE) and butyryl cholinesterase (BChE) enzymes supported by docking simulation studies and the IC50 values rendered a few of the synthesized molecules as moderate inhibitors of these enzymes where, the compound 3e exhibited comparatively better potency against alpha-glucosidase enzyme. The synthesized compounds showed weak or no inhibition against LOX, AChE and BChE enzymes.

PubMedSearch : Abbasi_2017_Pak.J.Pharm.Sci_30_1715
PubMedID: 29084694

Related information

Citations formats

Abbasi MA, Anwar A, Rehman A, Siddiqui SZ, Rubab K, Shah SAA, Lodhi MA, Khan FA, Ashraf M, Alam U (2017)
Synthesis, enzyme inhibition and molecular docking studies of 1-Arylsulfonyl-4-phenylpiperazine derivatives
Pak J Pharm Sci 30 :1715

Abbasi MA, Anwar A, Rehman A, Siddiqui SZ, Rubab K, Shah SAA, Lodhi MA, Khan FA, Ashraf M, Alam U (2017)
Pak J Pharm Sci 30 :1715